...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Halted

https://www.newswire.ca/news-releases/iiroc-trading-halt-zeni-p-895353782.html

Share
New Message
Please login to post a reply